Tenet Healthcare Corporation

Robbins Arroyo LLP Is Investigating the Officers and Directors of Tenet Healthcare Corporation (THC) on Behalf of Shareholders

Robbins Arroyo LLP is investigating whether certain officers and directors of Tenet Healthcare Corporation (NYSE: THC) violated the Anti-Kickback Statute in connection with a conspiracy to defraud the federal government. Tenet, together with its subsidiaries, primarily operates acute care hospitals and related healthcare facilities.

Tenet to Pay $513 Million Over Kickbacks

Tenet and two of its Atlanta subsidiaries recently agreed to pay $513 million to resolve claims accusing the chain of paying kickbacks to direct pregnant Medicaid patients to their hospitals. Under the pleas, the subsidiaries will forfeit $145 million, which is the amount the hospitals gained from Medicaid and Medicare funds. The hospital chain allegedly signed sham contracts for interpreter services with clinics that serve Hispanic women, and in exchange, the clinics sent pregnant customers to Tenet hospitals for deliveries that were billed to Medicaid from 2000 to 2013. The referrals caused the pregnant women to bypass other hospitals and travel farther during vulnerable times. Tenet also agreed to pay $368 million to settle alleged False Claims Act violations, with the United States receiving $244 million and the State of Georgia receiving most of the remainder.

Tenet Shareholders Have Legal Options

Concerned shareholders who would like more information about their rights and potential remedies can contact attorney Darnell R. Donahue at (800) 350-6003, or you can complete the form below and we will contact you directly.

 

Shareholder Information

Items marked with an asterisk (*) are required information.

First Name * Last Name *
Phone *
E-mail * Confirm: E-mail *
Number of Shares Owned:
Comments:

Please Note: Neither the submission to nor the receipt of information by Robbins Arroyo LLP or one of its attorneys through this website constitutes an agreement by our firm to represent the individual and does not create an attorney-client relationship. Please do not send confidential or sensitive information through this website. This information should be communicated through a direct contact with an individual at the firm.

* I have read the disclaimer information
+=

    Send This Post

    Tags: